MGEN - Miragen Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 0.74
52-Week Change 3-81.29%
S&P500 52-Week Change 318.08%
52 Week High 34.9600
52 Week Low 30.5700
50-Day Moving Average 30.7451
200-Day Moving Average 31.5726

Share Statistics

Avg Vol (3 month) 3165.16k
Avg Vol (10 day) 3157.51k
Shares Outstanding 531.79M
Float 23.81M
% Held by Insiders 110.65%
% Held by Institutions 149.79%
Shares Short (Oct 31, 2019) 4809k
Short Ratio (Oct 31, 2019) 44.19
Short % of Float (Oct 31, 2019) 42.95%
Short % of Shares Outstanding (Oct 31, 2019) 42.56%
Shares Short (prior month Sep 30, 2019) 4688.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 215/1
Last Split Date 3Nov 7, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-1,017.03%

Management Effectiveness

Return on Assets (ttm)-44.71%
Return on Equity (ttm)-100.31%

Income Statement

Revenue (ttm)4.06M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)-26.40%
Gross Profit (ttm)-22.04M
EBITDA -40.97M
Net Income Avi to Common (ttm)-42.07M
Diluted EPS (ttm)-1.3590
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)33.84M
Total Cash Per Share (mrq)1.06
Total Debt (mrq)9.23M
Total Debt/Equity (mrq)39.84
Current Ratio (mrq)3.68
Book Value Per Share (mrq)0.74

Cash Flow Statement

Operating Cash Flow (ttm)-36.42M
Levered Free Cash Flow (ttm)-20.51M